Navigation Links
Gene therapy slows progression of fatal neurodegenerative disease in children
Date:5/13/2008

New Rochelle, NY, May 13, 2008Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of print in the May 2008 issue (Vol. 19 No. 5) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online at www.liebertpub.com/hum

Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) is an autosomal recessive genetic disorder that causes degeneration of the central nervous system. It is a form of Batten disease, a group of lysosomal storage disease in which a lipofuscin-like material is not broken down and accumulates in neurons, causing cognitive impairment, visual failure, seizures, and progressive deterioration of motor function.

Ronald Crystal and colleagues from Weill Cornell Medical College (New York, NY), describe a study conducted in 10 children with LINCL who received gene therapy to replace the defective CLN2 gene via administration of human CLN2 carried in an adeno-associated virus (AAV). In the paper entitled Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis with CNS Administration of a Serotype 2 Adeno-associated virus expressing the CLN2 cDNA, the authors report that over an 18-month period, assessment using a neurologic rating scale demonstrated significant slowing of disease progression in the treated, compared to the untreated children. On the basis of these findings, the authors proposed that additional studies to assess the safety and efficacy of AAV-mediated gene therapy for LINCL be pursued.

Although the treatment was associated with some serious adverse events in some patients, these were not unequivocally attributable to the gene therapy vector.

This clinical trial is an important step toward the development of treatments for this group of underserved i
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
2. Cell-based therapy shows promise in patients with Parkinsons disease
3. Cancer immunotherapy shows long-term promise in lung cancer
4. Effective cancer immune therapy through order in the blood vessels
5. New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
6. Biomarkers allow doctors to match therapy to patient
7. MU researcher links hormone replacement therapy to breast cancer
8. Potential new target for multiple sclerosis therapy
9. Umbilical cord blood cell therapy may reduce signs and symptoms of Alzheimers disease
10. Umbilical cord blood cell therapy in an animal model of Alzheimers disease
11. Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... , June 22, 2015 ... announced the addition of the "Huawei Ascend ... report to their offering. Huawei,s ... to the opposite direction than Apple,s and Samsung,s ... fingerprint sensor developed by Fingerprint Cards, a main ...
(Date:6/23/2015)...   MedNet Solutions , an innovative SaaS-based ... of clinical research, is pleased to announce that ... company,s intuitive, flexible and affordable cloud-based eClinical technology ... Award by the American Business Awards (SM) ... The American Business Awards are considered the nation,s ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... developed analytical technique, a team led by scientists at USC ... in the ocean. "This is another twist to what ... biological and earth sciences at the USC Dornsife College of ... about the vitamin-depleted zones that will appear in Proceedings ...
... Connecticut researcher and his team have discovered that a ... blooms sometimes called "red tide" is even deadlier than ... chains. Professor Hans Dam and his research group ... that the plankton species Alexandrium tamarense contains ...
... Center for Laser Applications at the University of ... technology that goes on a "seek and destroy" ... power of lasers to find, map and non-invasively ... professor of physics, and Jacqueline Johnson, associate professor ...
Cached Biology News:Scientists confirm existence of vitamin 'deserts' in the ocean 2UConn researchers discover that 'red tide' species is deadlier than first thought 2University of Tennessee Space Institute researchers develop laser technology to fight cancer 2
(Date:7/7/2015)... ... July 07, 2015 , ... ... for biologic are some of the factors driving the pharmaceutical contract manufacturing market. ... as well as contract manufacturing organizations (CMOs), are driving market growth. Drug manufacturers ...
(Date:7/7/2015)... Mich. , July 7, 2015  Neogen Corporation ... signed an agreement to expand its relationship with Illumina ... and genomics. Under the agreement, Illumina will market and ... Illumina Infinium ® BeadArray technology, to the global ... largest agrigenomic customers through its GeneSeek ® genomics ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... driven community in the biometrical area. What began as a conference for European ... community for various functions in the biometrical area. Statistical Programmers, Data Managers and ...
(Date:7/6/2015)... ... July 06, 2015 , ... A ... new insights into how virulent fungi adapt through genetic modifications to fight back ... battle leaves them temporarily weakened. These insights may provide clues to new ways ...
Breaking Biology Technology:More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 3Neogen signs commercialization agreement with Illumina 2PhUSE Delighted to Welcome Member Number 5.000 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4
... 4, 2010 Four world-renowned,stem cell experts have recently given their ... Blood Bank" which has,just been established in the US by CORD:USE. , ... Cryo-Save ... pleased with this positive development. "We expect that the merit of,private storage ...
... Chinese researchers have successfully built an electromagnetic absorbing device ... cylinder comprising 60 concentric rings of metamaterials, is capable ... an astrophysical black hole (which, in space, soaks up ... Thursday, 3 June, in New Journal of Physics ...
... June 3 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), ... the newly created position of President and Chief Operating Officer. Dr. ... responsibility for its operations and infrastructure, in particular the development and ... , , ...
Cached Biology Technology:Scientists Give the Go-Ahead for Private Storage of Stem Cells From Umbilical Cord Blood 2Scientists Give the Go-Ahead for Private Storage of Stem Cells From Umbilical Cord Blood 3Scientists create artificial mini 'black hole' 2YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 2YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 3YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 4YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 5
... a base medium for preparation of minimal and ... but does not contain amino acids. Both bulk ... pouch contains reagents to prepare 500 ml of ... of 10X YNB for S. cerevisiae media. Store ...
... Progesterone Receptor (PR) Competitor Assay Kits ... novel progesterone receptor binding compounds using ... utilizes a fusion of glutathione transferase ... human progesterone receptor [PR-LBD(GST)] and a ...
... Protein G bind specifically to Fc regions ... Protein G conjugates are commonly used as ... immunoglobulin subtypes from serum, hybridoma ascites fluids, ... These reagents are also commonly used to ...
... the first instrument engineered to match the ... by thousands of research centers worldwide. It ... which are ideally suited for high-speed temperature ... extremely high surface-area-to-volume ratio. ,By combining glass ...
Biology Products: